compound 3l [PMID: 30637955]   Click here for help

GtoPdb Ligand ID: 10394

Compound class: Synthetic organic
Comment: Compound 3l is a potent and selective nonpeptide β-secretase 2 (BACE2) inhibitor [2]. It is one of the compounds claimed in patent US9512099 for use in the treatment of Alzheimer's disease or type 2 diabetes [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 15
Topological polar surface area 81.67
Molecular weight 617.29
XLogP 7.13
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1cc(cc(c1)C(=O)N(C(c1ccccc1)C)C)C(=O)NC(C(CNCc1cccc(c1)C(F)(F)F)O)Cc1ccccc1
Isomeric SMILES Cc1cc(cc(c1)C(=O)N([C@@H](c1ccccc1)C)C)C(=O)N[C@H]([C@@H](CNCc1cccc(c1)C(F)(F)F)O)Cc1ccccc1
InChI InChI=1S/C36H38F3N3O3/c1-24-17-29(21-30(18-24)35(45)42(3)25(2)28-14-8-5-9-15-28)34(44)41-32(20-26-11-6-4-7-12-26)33(43)23-40-22-27-13-10-16-31(19-27)36(37,38)39/h4-19,21,25,32-33,40,43H,20,22-23H2,1-3H3,(H,41,44)/t25-,32+,33-/m1/s1
InChI Key KQGVKXJLEHXBDS-CBHGIOBQSA-N
References
1. Ghosh AK. (2016)
Compounds for inhibition of memapsin 1.
Patent number: US9512099. Assignee: Purdue Research Foundation. Priority date: 12/09/2014. Publication date: 06/12/2016.
2. Ghosh AK, Brindisi M, Yen YC, Lendy EK, Kovela S, Cárdenas EL, Reddy BS, Rao KV, Downs D, Huang X et al.. (2019)
Highly Selective and Potent Human β-Secretase 2 (BACE2) Inhibitors against Type 2 Diabetes: Design, Synthesis, X-ray Structure and Structure-Activity Relationship Studies.
ChemMedChem, 14 (5): 545-560. [PMID:30637955]